Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1

References

• Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Polyomaviruses Hum Dis 2006; 577:19-45; PMID:16626025; http://dx.doi.org/10.1007/0-387-32957-9_2
   PubMed Web of Science ®Google Scholar
• Pietropaolo V, Videtta M, Fioriti D, Mischitelli M, Arancio A, Orsi N, Degener AM. Rearrangement patterns of JC virus noncoding control region from different biological samples. J Neurovirol 2003; 9:603-11; PMID:14602573; http://dx.doi.org/10.1080/714044482
   PubMed Web of Science ®Google Scholar
• Gorelik L, Reid C, Testa M, Brickelmaier M, Bossolasco S, Pazzi A, Bestetti A, Carmillo P, Wilson E, McAuliffe M, et al. Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change itsreceptor specificity. J Infect Dis 2011; 204:103-14; PMID:21628664; http://dx.doi.org/10.1093/infdis/jir198
   PubMed Web of Science ®Google Scholar
• Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, Pace A, Cheung A, Chen LL, Berman M, et al. Anti-JC virus antibodies: Implications for PML risk stratification. Annal Neurol 2010; 68:295-303; PMID:20737510; http://dx.doi.org/10.1002/ana.22128
   PubMed Web of Science ®Google Scholar
• Neu U, Maginnis MS, Palma AS, Stroeh LJ, Nelson CDS, Feizi T, Atwood WJ, Stehle T. Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host & Microbe 2010; 8:309-19; PMID:20951965; http://dx.doi.org/10.1016/j.chom.2010.09.004
   PubMed Web of Science ®Google Scholar
• Kishida S. Progressive multifocal leukoencephalopathy: epidemiology, clinical pictures, diagnosis and therapy. Brain and Nerve (Tokyo) 2007; 59:125-37; PMID:17380777
   PubMedGoogle Scholar
• Sunyaev SR, Lugovskoy A, Simon K, Gorelik L. Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML). Plos Genetics 2009; 5:e1000368; PMID:19197354; http://dx.doi.org/10.1371/journal.pgen.1000368
   PubMed Web of Science ®Google Scholar
• Tyler KL. Progressive multifocal leukoencephalopathy: can we reduce risk in patients receiving biological immunomodulatory therapies? Annal Neurol 2010; 68:271-4; PMID:20818784; http://dx.doi.org/10.1002/ana.22185
   PubMed Web of Science ®Google Scholar
• Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999; 52:253-60; PMID:9932940; http://dx.doi.org/10.1212/WNL.52.2.253
   PubMed Web of Science ®Google Scholar
• Rudick RA, O'Connor PW, Polman CH, Goodman AD, Ray SS, Griffith NM, Jurgensen SA, Gorelik L, Forrestal F, Sandrock AW, et al. Assessment of JC virus DNA in blood and urine from natalizumab-treated patients. Annal Neurol 2010; 68:304-10; PMID:20737514; http://dx.doi.org/10.1002/ana.22107
   PubMed Web of Science ®Google Scholar
• Neu U, Stehle T, Atwood WJ. The Polyomaviridae: contributions of virus structure to our understanding of virus receptors and infectious entry. Virology 2009; 384:389-99; PMID:19157478; http://dx.doi.org/10.1016/j.virol.2008.12.021
   PubMed Web of Science ®Google Scholar
• Liu CK, Wei G, Atwood WJ. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. J Virol 1998; 72:4643-9; PMID:9573227
   PubMed Web of Science ®Google Scholar
• Chen BJ, Atwood WJ. Construction of a novel JCV/SV40 hybrid virus (JCSV) reveals a role for the JCV capsid in viral tropism. Virology 2002; 300:282-90; PMID:12350358; http://dx.doi.org/10.1006/viro.2002.1522
   PubMed Web of Science ®Google Scholar
• Reid CE, Li H, Sur G, Carmillo P, Bushnell S, Tizard R, McAuliffe M, Tonkin C, Simon K, Goelz S, et al. Sequencing and analysis of JC virus DNA from Natalizumab-treated PML patients. J Infect Dis 2011; 204:237-44; PMID:21673034; http://dx.doi.org/10.1093/infdis/jir256
   PubMed Web of Science ®Google Scholar
• Maginnis MS, Ströh LJ, Gee GV, O'Hara BA, Derdowski A, Stehle T, Atwood WJ. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding. mBio 2013; 4:e00247-13; PMID:23760462; http://dx.doi.org/10.1128/mBio.00247-13
   PubMedGoogle Scholar
• Kondo Y, Windrem MS, Zou L, Chandler-Militello D, Schanz SJ, Auvergne RM, Betstadt SJ, Harrington AR, Johnson M, Kazarov A, et al. Human glial chimeric mice reveal astrocytic dependence of JC virus infection. J Clin Invest 2014; 124:5323-36; PMID:25401469; http://dx.doi.org/10.1172/JCI76629
   PubMed Web of Science ®Google Scholar
• Bradbury ARM, Sidhu S, Dübel S, McCafferty J. Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol 2011; 29:245-54; PMID:21390033; http://dx.doi.org/10.1038/nbt.1791
   PubMed Web of Science ®Google Scholar
• Gao J, Sidhu SS, Wells JA. Two-state selection of conformation-specific antibodies. Proc Natl Acad Sci U S A 2009; 106:3071-6; PMID:19208804; http://dx.doi.org/10.1073/pnas.0812952106
   PubMed Web of Science ®Google Scholar
• Hattori T, Taft JM, Swist KM, Luo H, Witt H, Slattery M, Koide A, Ruthenburg AJ, Krajewski K, Strahl BD, et al. Recombinant antibodies to histone post-translational modifications. Nat Methods 2013; 10:992-5; PMID:23955773; http://dx.doi.org/10.1038/nmeth.2605
   PubMed Web of Science ®Google Scholar
• Lua LHL, Connors NK, Sainsbury F, Chuan YP, Wibowo N, Middelberg APJ. Bioengineering virus-like particles as vaccines. Biotech Bioeng 2014; 111:425-40; PMID:24347238; http://dx.doi.org/10.1002/bit.25159
   PubMed Web of Science ®Google Scholar
• Xin X, Gfeller D, Cheng J, Tonikian R, Sun L, Guo A, Lopez L, Pavlenco A, Akintobi A, Zhang Y, et al. SH3 interactome conserves general function over specific form. Mol Sys Biol 2013; 9; PMID:23549480
   PubMed Web of Science ®Google Scholar
• Persson H, Ye W, Wernimont A, Adams JJ, Koide A, Koide S, Lam R, Sidhu SS. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies. J Mol Biol 2013; 425:803-11; PMID:23219464; http://dx.doi.org/10.1016/j.jmb.2012.11.037
   PubMed Web of Science ®Google Scholar
• Vajdos FF, Adams CW, Breece TN, Presta LG, De Vos AM, Sidhu SS. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis. J Mol Biol 2002; 320:415-28; PMID:12079396; http://dx.doi.org/10.1016/S0022-2836(02)00264-4
   PubMed Web of Science ®Google Scholar
• Karauzum H, Chen G, Abaandou L, Mahmoudieh M, Boroun AR, Shulenin S, Devi VS, Stavale E, Warfield KL, Zeitlin L, et al. Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome. J Biol Chem 2012; 287:25203-15; PMID:22645125; http://dx.doi.org/10.1074/jbc.M112.364075
   PubMed Web of Science ®Google Scholar
• Sidhu SS, Lowman HB, Cunningham BC, Wells JA. Phage display for selection of novel binding peptides. Applications of Chimeric Genes and Hybrid Proteins, Pt C, 2000:333-63; PMID:11075354; http://dx.doi.org/10.1016/S0076-6879(00)28406-1
   PubMedGoogle Scholar
• Sidhu SS. Phage display in pharmaceutical biotechnology. Curr Opin Biotech 2000; 11:610-6; PMID:11102798; http://dx.doi.org/10.1016/S0958-1669(00)00152-X
   PubMed Web of Science ®Google Scholar
• Sidhu SS, Li B, Chen Y, Fellouse FA, Eigenbrot C, Fuh G. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions. J Mol Biol 2004; 338:299-310; PMID:15066433; http://dx.doi.org/10.1016/j.jmb.2004.02.050
   PubMed Web of Science ®Google Scholar
• Lee CV, Liang WC, Dennis MS, Eigenbrot C, Sidhu SS, Fuh G. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J Mol Biol 2004; 340:1073-93; PMID:15236968; http://dx.doi.org/10.1016/j.jmb.2004.05.051
   PubMed Web of Science ®Google Scholar
• Fellouse FA, Esaki K, Birtalan S, Raptis D, Cancasci VJ, Koide A, Jhurani P, Vasser M, Wiesmann C, Kossiakoff AA, et al. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J Mol Biol 2007; 373:924-40; PMID:17825836; http://dx.doi.org/10.1016/j.jmb.2007.08.005
   PubMed Web of Science ®Google Scholar
• Sidhu SS, Fellouse FA. Synthetic therapeutic antibodies. Nat Chem Biol 2006; 2:682-8; PMID:17108986; http://dx.doi.org/10.1038/nchembio843
   PubMed Web of Science ®Google Scholar
• Paduch M, Koide A, Uysal S, Rizk SS, Koide S, Kossiakoff AA. Generating conformation-specific synthetic antibodies to trap proteins in selected functional states. Methods 2013; 60:3-14; PMID:23280336; http://dx.doi.org/10.1016/j.ymeth.2012.12.010
   PubMed Web of Science ®Google Scholar
• Pál G, Fong SY, Kossiakoff AA, Sidhu SS. Alternative views of functional protein binding epitopes obtained by combinatorial shotgun scanning mutagenesis. Protein Sci 2005; 14:2405-13; PMID:16131663; http://dx.doi.org/10.1110/ps.051519805
   PubMed Web of Science ®Google Scholar
• Murase K, Morrison KL, Tam PY, Stafford RL, Jurnak F, Weiss GA. EF-Tu binding peptides identified, dissected, and affinity optimized by phage display. Chem Biol 2003; 10:161-8; PMID:12618188; http://dx.doi.org/10.1016/S1074-5521(03)00025-5
   PubMed Web of Science ®Google Scholar
• Fellouse FA, Li B, Compaan DM, Peden AA, Hymowitz SG, Sidhu SS. Molecular recognition by a binary code. J Mol Biol 2005; 348:1153-62; PMID:15854651; http://dx.doi.org/10.1016/j.jmb.2005.03.041
   PubMed Web of Science ®Google Scholar
• Fellouse FA, Wiesmann C, Sidhu SS. Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci U S A 2004; 101:12467-72.
   PubMed Web of Science ®Google Scholar
• Kunkel TA, Roberts JD, Zakour RA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Method Enzymol 1987; 154:367-82; PMID:3323813; http://dx.doi.org/10.1016/0076-6879(87)54085-X
   PubMed Web of Science ®Google Scholar
• Fellouse FA, Sidhu SS. Making antibodies in bacteria. In: Howard GC, Kaser MR, eds. Making and using antibodies: a practical handbook. Boca Raton, FL: CRC Press; 2006, 157-80.
   Google Scholar
• Atwood WJ, Wang L, Durham LC, Amemiya K, Traub RG, Major EO. Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial-cells. J Neurovirol 1995; 1:40-9; PMID:9222341; http://dx.doi.org/10.3109/13550289509111009
   PubMed Web of Science ®Google Scholar
• Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of proteins of immunological interest. Bethesda, MD: National Institutes of Health; 1991.
   Google Scholar